Cambridge Trust’s ResMed RMD Stock Holding History

Cambridge Trust’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6	Closed	-$1K	–	870
2022 Q3	$1K	Buy	+6	New	+$1.37K	﹤0.01%	822
2022 Q1	–	Sell	-125	Closed	-$33K	–	1119
2021 Q4	$33K	Buy	+125	New	+$32.4K	﹤0.01%	602

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Cambridge Trust's RMD Position: Q4 2022 in Review

Cambridge Trust sold out of ResMed (RMD) in Q4 2022, closing a stake of 6 shares — an estimated $1K sold.

Cambridge Trust first reported a position in RMD in Q4 2021 and held it in 2 quarters. The position peaked at $33K in Q4 2021. 731 funds tracked by Wall St. Rank hold RMD as of Q4 2022.

Cambridge Trust reported no remaining ResMed position as of Q4 2022 after selling out during the quarter.
Cambridge Trust sold 6 ResMed shares in Q4 2022, an estimated $1K.
Cambridge Trust first reported a position in ResMed in Q4 2021 and held it in 2 quarters.
Cambridge Trust's ResMed position peaked at $33K in Q4 2021.
731 funds tracked by Wall St. Rank held ResMed as of Q4 2022.

Based on Cambridge Trust's 13F filing for Q4 2022, filed 10 Jan 2023.